Durai Sundar

19PUBLICATIONS
30CO-AUTHORS
Molecular targetsBiomolecular modelling and designPredictive and prognostic markersBiologically active moleculesPyrometallurgy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 15, 2026
Selective killing of ALT-cancer cells by Withaferin-A involves destabilization of Rad51 and disruption of DNA repair.

|Jan 25, 2025
Establishing a General Atomistic Model for the Stratum Corneum Lipid Matrix Based on Experimental Data for Skin Permeation Studies.

Navaneethan Radhakrishnan, Sunil C Kaul, Renu Wadhwa

|Oct 26, 2024
Synthetic and Natural Inhibitors of Mortalin for Cancer Therapy.

Shruti Kaushal, Samriddhi Gupta, Seyad Shefrin

|Sep 14, 2024
Molecular Insights into the Anticancer Activity of Withaferin-A: The Inhibition of Survivin Signaling.

Renu Wadhwa, Jia Wang, Seyad Shefrin

|Jul 22, 2024
Identifying High-Quality Leads among Screened Anticancerous Compounds Using SMILES Representations.

Swathik Clarancia Peter, Yogesh Kalakoti, Durai Sundar

|Jan 04, 2024
M-Ionic: prediction of metal-ion-binding sites from sequence using residue embeddings.

Aditi Shenoy, Yogesh Kalakoti, Durai Sundar

Pageof 4

Frequent Collaborators

6 joint publications

Renu Wadhwa

3 joint publications

Navaneethan Radhakrishnan

3 joint publications

Shashank Yadav

2 joint publications

Arindam Maitra